| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |